Tmunity Therapeutics inks $75 mln Series B

Philadelphia-based Tmunity Therapeutics, a biotherapeutics firm, has secured $75 million in Series B financing. Andreessen Horowitz led the round.

31 October 2019•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles